NEW: We've expanded Stock Detail, Screener, and Maps with new data

Stock Detail, Screener:
3, 5, 10-Year Performance
EV/EBITDA, EV/Sales
Dividend Growth (1, 3, 5 Years)
EPS & Sales Growth (3 Years)

Maps:
All from Screener plus:
ROA, ROE, ROIC
Quick & Current Ratios
LT Debt and Debt to Equity Ratios
Gross, Operating, and Net Margins

TGTX

TG Therapeutics Inc

Jul 02 • 10:04AM ET

35.69

Dollar change +0.29
Percentage change 0.82	%

Healthcare • Biotechnology • USA • NASD

Peers: BLUE GILD RARE JAZZ NBIX SRPT AKBA PTCT AUPH XOMA

| Held by: IJR VTI IWM VB XBI VXF VBK IWO IJT SPSM

Scroll to Statements

Index	RUT	P/E	146.27	EPS (ttm)	0.24	Insider Own	10.00%	Shs Outstand	158.17M	Perf Week	-4.21%
Market Cap	5.67B	Forward P/E	20.37	EPS next Y	1.75	Insider Trans	-0.20%	Shs Float	142.87M	Perf Month	-0.17%
Enterprise Value	5.64B	PEG	0.95	EPS next Q	0.19	Inst Own	62.51%	Short Float	16.59%	Perf Quarter	-5.46%
Income	39.15M	P/S	14.66	EPS this Y	467.78%	Inst Trans	1.37%	Short Ratio	9.57	Perf Half Y	9.71%
Sales	386.39M	P/B	23.79	EPS next Y	105.68%	ROA	7.60%	Short Interest	23.70M	Perf YTD	18.57%
Book/sh	1.50	P/C	20.51	EPS next 5Y	153.20%	ROE	19.70%	52W High	46.48 -23.21%	Perf Year	100.62%
Cash/sh	1.74	P/FCF	-	EPS past 3/5Y	- -	ROIC	7.99%	52W Low	16.65 114.35%	Perf 3Y	722.35%
Dividend Est.	-	EV/EBITDA	93.93	Sales past 3/5Y	266.39% 364.59%	Gross Margin	87.36%	Volatility	3.95% 4.18%	Perf 5Y	87.64%
Dividend TTM	-	EV/Sales	14.61	EPS Y/Y TTM	-6.13%	Oper. Margin	15.48%	ATR (14)	1.48	Perf 10Y	108.71%
Dividend Ex-Date	-	Quick Ratio	3.04	Sales Y/Y TTM	33.54%	Profit Margin	10.13%	RSI (14)	45.07	Recom	1.38
Dividend Gr. 3/5Y	- -	Current Ratio	4.02	EPS Q/Q	142.49%	SMA20	-3.81%	Beta	1.96	Target Price	43.50
Payout	0.00%	Debt/Eq	1.07	Sales Q/Q	90.40%	SMA50	-3.69%	Rel Volume	0.49	Prev Close	35.40
Employees	338	LT Debt/Eq	1.06	Earnings	May 05 BMO	SMA200	9.41%	Avg Volume	2.48M	Price	35.69
IPO	Dec 14, 1995	Option/Short	Yes / Yes	EPS/Sales Surpr.	-82.53% 2.53%	Trades		Volume	160,384	Change	0.82%

Date	Action	Analyst	Rating Change	Price Target Change
Oct-29-24	Initiated	TD Cowen	Buy	$50
Aug-02-23	Upgrade	Goldman	Sell → Neutral	$16 → $12
Jun-26-23	Resumed	Jefferies	Buy	$55 → $40
May-20-22	Initiated	BofA Securities	Underperform	$5
Feb-23-22	Reiterated	B. Riley Securities	Buy	$49 → $35
Nov-15-21	Downgrade	Goldman	Neutral → Sell	$33 → $26
Apr-20-21	Initiated	Goldman	Neutral	$50
Apr-19-21	Reiterated	H.C. Wainwright	Buy	$79 → $89
Sep-01-20	Initiated	JP Morgan	Overweight	$38
Aug-11-20	Reiterated	H.C. Wainwright	Buy	$32 → $38
Jun-05-20	Initiated	Evercore ISI	Outperform	$60
Jan-17-20	Reiterated	H.C. Wainwright	Buy	$20 → $24
Nov-27-19	Resumed	B. Riley FBR	Buy	$12
Feb-06-19	Resumed	Jefferies	Buy	$8
Sep-25-18	Downgrade	Raymond James	Strong Buy → Outperform
Mar-09-18	Reiterated	B. Riley FBR, Inc.	Buy	$21.50 → $27
Dec-01-17	Resumed	B. Riley FBR, Inc.	Buy	$21.50
Nov-14-17	Resumed	H.C. Wainwright	Buy	$33
Apr-25-17	Initiated	Jefferies	Buy
Mar-06-17	Reiterated	FBR & Co.	Outperform	$24 → $26

Show Previous Ratings

Jun-30-25 09:22PM	Lightning Round: Buy anything uranium, says Jim Cramer (CNBC TV)
Jun-16-25 09:47AM	Are Options Traders Betting on a Big Move in TG Therapeutics Stock? (Zacks)
Jun-06-25 07:30AM	TG Therapeutics to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference (GlobeNewswire)
Jun-02-25 08:00AM	TG Therapeutics to Participate in the Jefferies Global Healthcare Conference (GlobeNewswire)
May-30-25 07:30AM	TG Therapeutics Announces Data Presentations for BRIUMVI in Multiple Sclerosis at the 2025 Consortium of Multiple Sclerosis Centers Annual Meeting (GlobeNewswire)
07:30AM	Loading…
May-27-25 07:30AM	TG Therapeutics Announces Schedule of Data Presentations for BRIUMVI in Multiple Sclerosis at the 2025 Consortium of Multiple Sclerosis Centers Annual Meeting (GlobeNewswire)
May-19-25 06:20AM	Should First Trust Small Cap Core AlphaDEX ETF (FYX) Be on Your Investing Radar? (Zacks)
May-09-25 10:28AM	TG Therapeutics, Inc. (TGTX): Among the Best Cancer Stocks to Invest in for Long-Term Gain (Insider Monkey)
May-06-25 03:03AM	TG Therapeutics Inc (TGTX) Q1 2025 Earnings Call Highlights: Strong BRIUMVI Sales and Increased ... (GuruFocus.com) -7.48%
May-05-25 11:20PM	Q1 2025 TG Therapeutics Inc Earnings Call (Thomson Reuters StreetEvents) -13.26%
03:37PM	Why TG Therapeutics Stock Was Tumbling Today (Motley Fool)
01:30PM	TG Therapeutics: Share Price Slip On Q1 Earnings Unsurprising Given Challenges (Seeking Alpha)
10:55AM	TG Therapeutics, Inc. (TGTX) Q1 2025 Earnings Call Transcript (Seeking Alpha)
08:10AM	TG Therapeutics (TGTX) Lags Q1 Earnings Estimates (Zacks)
07:08AM	TG Therapeutics: Q1 Earnings Snapshot (Associated Press Finance)
07:00AM	Loading…
07:00AM	TG Therapeutics Reports First Quarter 2025 Financial Results and Raises BRIUMVI Full Year Revenue Guidance (GlobeNewswire)
May-01-25 09:20AM	Alnylam Pharmaceuticals (ALNY) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
Apr-30-25 10:01AM	TG Therapeutics (TGTX) to Report Q1 Results: Wall Street Expects Earnings Growth (Zacks)
07:30AM	TG Therapeutics to Host Conference Call on First Quarter 2025 Financial Results and Business Update (GlobeNewswire)
Apr-28-25 06:20AM	Is First Trust Small Cap Core AlphaDEX ETF (FYX) a Strong ETF Right Now? (Zacks)
Apr-23-25 06:06PM	BBSC: Lagging Several Small-Cap Core ETFs (Seeking Alpha)
01:59AM	TG Therapeutics: Considering If The Promise Of Accelerated Revenue Growth Is Enough (Seeking Alpha)
Apr-16-25 11:32AM	TG Therapeutics: Progress In MS Tempered By High Expectations (Seeking Alpha)
Apr-10-25 11:50AM	TG Therapeutics Shares Rise Almost 30% in 3 Months: Here's Why (Zacks)
07:30AM	TG Therapeutics Announces Data Presentations for BRIUMVI in Multiple Sclerosis at the American Academy of Neurology 2025 Annual Meeting (GlobeNewswire)
Apr-08-25 07:30AM	TG Therapeutics Announces Data Presentations for BRIUMVI in Multiple Sclerosis at the American Academy of Neurology 2025 Annual Meeting (GlobeNewswire)
Apr-07-25 03:08PM	Zenas: Differentiated B-Cell Targeting Drug With Q3 Of 2025 Catalyst (Seeking Alpha)
08:00AM	ClearBridge Small Cap Growth Strategy Q1 2025 Commentary (Seeking Alpha)
07:30AM	TG Therapeutics Announces Two Publications Highlighting BRIUMVI in Medical Journals (GlobeNewswire)
Apr-03-25 05:00AM	'Trump Bump' Hits A Slump: 8 Stocks For A Downturn (Seeking Alpha)
04:35PM	Loading…
Apr-02-25 04:35PM	IBD 50 Stock TG Therapeutics Rallies On A Setback For Chief Rival Roche (Investor's Business Daily) +5.48%
Mar-28-25 09:44AM	AbbVie Vs. Sanofi: Which Is The Better Investment Right Now (Seeking Alpha)
Mar-21-25 03:22PM	These Insurance Stocks And Biotech Leader Hit New Highs As Stock Market Crumbles (Investor's Business Daily)
Mar-19-25 04:16PM	TG Therapeutics (TGTX): Among the Best Short Squeeze Stocks to Buy According to Analysts (Insider Monkey) +6.49%
Mar-17-25 05:33AM	Strength Seen in TG Therapeutics (TGTX): Can Its 10.2% Jump Turn into More Strength? (Zacks)
Mar-14-25 10:36AM	Is TG Therapeutics, Inc. (TGTX) the Best Performing Growth Stock in 2025? (Insider Monkey) +10.20%
Mar-11-25 09:49AM	Biotech Stock TG Therapeutics Hits A High In Market Meltdown (Investor's Business Daily)
Mar-08-25 12:05PM	S&P 500 Pair, Warren Buffet Pick Lead Five Stocks Near Buy Points Amid Market Shakeout (Investor's Business Daily)
Mar-07-25 05:23PM	Why TG Therapeutics Stock Was Soaring This Week (Motley Fool) +9.24%
07:30AM	TG Therapeutics Announces Schedule of Data Presentations for BRIUMVI (ublituximab) in Multiple Sclerosis at the American Academy of Neurology 2025 Annual Meeting (GlobeNewswire)
Mar-06-25 12:22PM	This Biotech Stock Hits Buy Point After Earnings Burst (Investor's Business Daily)
Mar-04-25 05:09AM	Why TG Therapeutics, Inc. (TGTX) Surged On Monday? (Insider Monkey)
02:01AM	TG Therapeutics Inc (TGTX) Q4 2024 Earnings Call Highlights: Strong U.S. ... (GuruFocus.com)
12:42AM	Q4 2024 TG Therapeutics Inc Earnings Call (Thomson Reuters StreetEvents)
Mar-03-25 05:08PM	TG Therapeutics soared 17% after earnings surprise (TheStreet) +14.39%
04:19PM	TG Therapeutics, A New Leaderboard Stock, Skyrockets 14% On Sales Beat, Bullish Guide (Investor's Business Daily)
04:10PM	Meta, Netflix Hold Tough As Tech Tanks. This Biotech Booms. (Investor's Business Daily)
02:25PM	Meta, Netflix Test These Upper Limits As Tesla Exits The Scene While This Biotech Booms (Investor's Business Daily)
12:55PM	TG Therapeutics Soars Nearly 18% as Strong Q4 Results Fuel Growth Optimism (GuruFocus.com)
07:26AM	TG Therapeutics: Q4 Earnings Snapshot (Associated Press Finance)
07:00AM	TG Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2024 Financial Results (GlobeNewswire)
Feb-27-25 07:30AM	TG Therapeutics Announces Presentation of Data for BRIUMVI in Multiple Sclerosis at the Americas Committee for Treatment and Research in Multiple Sclerosis Annual Forum (GlobeNewswire)
Feb-26-25 07:30AM	TG Therapeutics to Host Conference Call on Fourth Quarter and Full Year 2024 Financial Results and Business Update (GlobeNewswire)
Feb-18-25 07:30AM	TG Therapeutics Announces Schedule of Data Presentations for BRIUMVI (ublituximab) in Multiple Sclerosis at the Americas Committee for Treatment and Research in Multiple Sclerosis Annual Forum (GlobeNewswire)
Feb-12-25 08:00AM	How Small, But 'Mighty' TG Therapeutics Scored A 470% Gain Over 13 Months (Investor's Business Daily)
Jan-27-25 12:00PM	All You Need to Know About TG Therapeutics (TGTX) Rating Upgrade to Buy (Zacks)
Jan-20-25 06:41PM	Heres Why Analysts Are Bullish on TG Therapeutics, Inc. (TGTX) (Insider Monkey)
Jan-15-25 10:29AM	Is TG Therapeutics Inc. (TGTX) Among Tuesdays Top Gainers? (Insider Monkey)
08:15AM	TG Therapeutics (TGTX) Moves 7.5% Higher: Will This Strength Last? (Zacks)
Jan-14-25 03:00PM	Why TGTX Stock Is Rallying Today (Insider Monkey) +7.48%
07:00AM	TG Therapeutics Provides Preliminary Fourth Quarter and Full Year 2024 Net Revenue and 2025 Anticipated Development Milestones (GlobeNewswire)
Jan-10-25 07:32AM	Should You Invest in TG Therapeutics (TGTX)? (Insider Monkey)
Jan-09-25 07:30AM	TG Therapeutics to Participate in the 43rd Annual J.P. Morgan Healthcare Conference (GlobeNewswire)
Jan-08-25 07:25AM	TG Therapeutics price target raised to $10 from $9 at BofA (TipRanks)
Dec-24-24 10:58PM	Will TG Therapeutics, Inc. (TGTX) Make You Rich In 2025? (Insider Monkey)
Nov-29-24 08:00AM	TG Therapeutics to Participate in the Evercore HealthCONx Conference (GlobeNewswire)
Nov-26-24 06:45AM	TG Therapeutics price target raised to $43 from $30 at JPMorgan (TipRanks)
Nov-21-24 12:35PM	TG Therapeutics Stock Soars Nearly 15% After Topping Deloitte's Fast 500 and Raising Revenue Outlook (GuruFocus.com) +10.91%
06:00AM	TG Therapeutics Ranked Number One Fastest-Growing Company in North America on the 2024 Deloitte Technology Fast 500 (GlobeNewswire)
Nov-05-24 02:02AM	TG Therapeutics Inc (TGTX) Q3 2024 Earnings Call Highlights: Record Revenue Growth and ... (GuruFocus.com) +6.16%
01:17AM	Q3 2024 TG Therapeutics Inc Earnings Call (Thomson Reuters StreetEvents)
Nov-04-24 04:15PM	AI Stocks Meta, Oracle Lead Five Names Near Buy Points (Investor's Business Daily) -9.44%
04:07PM	TG Therapeutics Crashes Reversing A Breakout After Missing 'Whisper' Expectations (Investor's Business Daily)
09:00AM	FUJIFILM Diosynth Biotechnologies Signs Manufacturing Supply Agreement with TG Therapeutics (GlobeNewswire)
08:10AM	TG Therapeutics (TGTX) Lags Q3 Earnings Estimates (Zacks)
07:06AM	TG Therapeutics: Q3 Earnings Snapshot (Associated Press Finance)
07:00AM	TG Therapeutics Reports Third Quarter 2024 Financial Results and Raises BRIUMVI (ublituximab-xiiy) Full Year Revenue Guidance (GlobeNewswire)
Nov-01-24 08:06AM	TG Therapeutics to Host Conference Call on Third Quarter 2024 Financial Results and Business Update (GlobeNewswire) +7.34%
Oct-31-24 03:44PM	Is TG Therapeutics, Inc. (TGTX) Set to Explode in 2025? (Insider Monkey)
Sep-21-24 12:38AM	TG Therapeutics Inc (TGTX): Short Seller Sentiment is Bearish (Insider Monkey)
Sep-18-24 04:20PM	IBD 50's TG Therapeutics Rises On Five-Year Data For Multiple Sclerosis Drug (Investor's Business Daily)
04:09PM	Stocks Reverse Lower After Fed's Half-Point Rate Cut; Donald Trump Stock Slammed Again (Live Coverage) (Investor's Business Daily)
03:29PM	Small-Cap Stocks Lead Volatile Action After Fed's Half-Point Rate Cut; Meta, Carpenter Near Buy Points, But Donald Trump Stock Slammed Again (Live Coverage) (Investor's Business Daily)
02:41PM	Indexes Turn Bullishly Higher On Fed's Half-Point Rate Cut; Donald Trump Stock Slammed Again (Live Coverage) (Investor's Business Daily)
01:44PM	Indexes Mixed Ahead Of Fed Decision, But Donald Trump Stock Slammed Again; Majority Of Magnificent Seven Stocks Fall (Live Coverage) (Investor's Business Daily)
12:28PM	Indexes Stall Ahead Of Fed Decision, Donald Trump Stock Slammed Again; Most Magnificent Seven Stocks Fall (Live Coverage) (Investor's Business Daily)
10:46AM	Indexes Move Quietly Ahead Of Fed Decision; Google Stock Rises 6th Straight Day On Victory In EU Spat (Live Coverage) (Investor's Business Daily)
07:15AM	New BRIUMVI (ublituximab-xiiy) Data from the ENHANCE Phase 3b Study Show Rapid 30-Minute Infusions are Well Tolerated in Patients with Relapsing Forms of Multiple Sclerosis (GlobeNewswire)
07:00AM	New Data for BRIUMVI (ublituximab-xiiy) Demonstrate that 92% of Patients with Relapsing Multiple Sclerosis Were Free from Disability Progression After 5 Years of Treatment (GlobeNewswire)
Sep-06-24 06:43PM	Palantir Technologies, Dell Technologies, and Erie Indemnity Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600 (PR Newswire) +7.81%
01:31PM	Four Biotech Stocks Rally Toward Buy Points As Funds Load Up (Investor's Business Daily)
Sep-05-24 07:30AM	TG Therapeutics Announces Schedule of Data Presentations for BRIUMVI at the 2024 European Committee for Treatment and Research in Multiple Sclerosis Annual Meeting (GlobeNewswire)
Aug-30-24 10:38AM	TG Therapeutics Inc (NASDAQ:TGTX) A Bull Case Theory (Insider Monkey)
Aug-19-24 04:00PM	IBD 50 Stock TG Therapeutics Breaks Out Bullishly After 'Solid' Quarter (Investor's Business Daily) +14.09%
Aug-16-24 04:23PM	IBD Stock Of The Day TG Therapeutics Flirts With Two Breakouts On Its Newfound Profitability (Investor's Business Daily) +5.44%
Aug-12-24 04:32AM	FDA grants IND clearance for TG Therapeutics trial of multiple sclerosis treatment (Clinical Trials Arena)
Aug-06-24 04:00PM	TG Therapeutics Stock Rockets As Surprise Profit Smashes Views By 157% (Investor's Business Daily) +19.58%
09:46AM	TG Therapeutics Stock Jumps As Surprise Profit Smashes Views By 157% (Investor's Business Daily)
08:15AM	TG Therapeutics (TGTX) Surpasses Q2 Earnings and Revenue Estimates (Zacks)
07:18AM	TG Therapeutics: Q2 Earnings Snapshot (Associated Press Finance)

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Echelard Yann	Director	Jun 13 '25	Sale	36.94	10,000	369,400	228,816	Jun 16 05:47 PM
Echelard Yann	Director	Jun 13 '25	Proposed Sale	36.93	10,000	369,348		Jun 13 12:48 PM
Power Sean A	CFO	Jan 03 '25	Sale	30.29	11,337	343,443	670,632	Jan 07 06:01 PM
Power Sean A	CFO	Jan 06 '25	Sale	28.53	10,021	285,939	660,611	Jan 07 06:01 PM
Power Sean A	Officer	Jan 06 '25	Proposed Sale	28.53	10,021	285,941		Jan 06 04:06 PM
Power Sean A	Officer	Jan 03 '25	Proposed Sale	30.29	11,337	343,448		Jan 03 04:52 PM
Lonial Sagar	Director	Nov 11 '24	Sale	30.44	5,000	152,200	100,195	Nov 12 05:02 PM
Charney Laurence N	Director	Nov 11 '24	Sale	30.20	25,000	754,875	212,479	Nov 12 05:01 PM
Charney Laurence N	Director	Nov 11 '24	Proposed Sale	30.19	25,000	754,873		Nov 12 11:36 AM
Lonial Sagar	Director	Nov 11 '24	Proposed Sale	30.44	5,000	152,200		Nov 12 11:12 AM
Echelard Yann	Director	Nov 05 '24	Sale	24.48	20,000	489,600	224,098	Nov 07 04:35 PM
Echelard Yann	Director	Nov 05 '24	Proposed Sale	24.48	20,000	489,500		Nov 05 01:42 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

TGTX

TG Therapeutics Inc

Upgrade your FINVIZ experience